I. Haro

Martha Ariza-Sáenz, M. Espina, A. Calpena, 2017, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

The incorporation of sugar moieties to neuropeptides: comparative study of different methods

I. Haro, J. García-Antón, E. Bardaji, 1988 .

Surface behaviour and peptide–lipid interactions of the E1(3-17)R and E1(3-17)G peptides from E1 capside protein of GBV-C/HGV virus

I. Haro, M. Alsina, M. Pujol, 2008 .

Physicochemical Study of Several Peptide Constructs Based on the Sequence (96–107) of VP2-HAV Protein

I. Haro, M. Busquets, M. Alsina, 1997 .

Interaction energies of cholesterol, phosphatidylserine, and phosphatidylcholine in spread mixed monolayers at the air-water interface

M. Espina, I. Haro, M. Alsina, 1991 .

Antigenicity of chimeric and cyclic synthetic peptides based on nonstructural proteins of GBV‐C/HGV

W. Chan, I. Haro, G. Ercilla, 2006, Journal of peptide science : an official publication of the European Peptide Society.

Miscibility of the hepatocyte membrane lipids at the air/water interface and interaction with the sequence (110-121) of the capsid protein VP3 of hepatitis A virus

I. Haro, M. Alsina, Y. Cajal, 1999 .

Diagnostic Value of Anti‐GBV‐C Antibodies in HIV‐Infected Patients

H. Tillmann, I. Haro, S. Tenckhoff, 2011, Chemical biology & drug design.

Interfacial properties of a synthetic peptide derived from hepatitis G virus E2 protein: interaction with lipid monolayers.

M. Espina, I. Haro, M. Alsina, 2006, Langmuir : the ACS journal of surfaces and colloids.

Effects of overlapping GB virus C/hepatitis G virus synthetic peptides on biomembrane models.

I. Haro, M. Busquets, M. Alsina, 2004, Langmuir : the ACS journal of surfaces and colloids.

Study in mono and bilayers of the interaction of hepatitis G virus (GBV-C/HGV) synthetic antigen E2(99-118) with cell membrane phospholipids.

I. Haro, N. Rojo, M. Alsina, 2004, Biophysical chemistry.

HIV-1 inhibiting capacity of novel forms of presentation of GB virus C peptide domains is enhanced by coordination to gold compounds.

J. Gatell, I. Haro, E. Yuste, 2013, Current medicinal chemistry.

Design of synthetic peptidic constructs for the vaccine development against viral infections.

I. Haro, M. Gómara, 2004, Current protein & peptide science.

Fluorescence analysis of the interaction of two peptide sequences of hepatitis GB virus C with liposomes.

I. Haro, N. Rojo, M. Busquets, 2003, Talanta.

Fluorescence study of the dynamic interaction between E1(145–162) sequence of hepatitis GB virus C and liposomes

J. Amigo, I. Haro, M. Busquets, 2009, Analytical and bioanalytical chemistry.

Effect of amino acid sequence change on peptide-membrane interaction

I. Haro, M. Busquets, P. Sospedra, 2002 .

Effective In Vivo Topical Delivery of siRNA and Gene Silencing in Intact Corneal Epithelium Using a Modified Cell-Penetrating Peptide

M. Nesbit, I. Haro, Davide Schiroli, 2019, Molecular therapy. Nucleic acids.

Lipid Vesicles Loaded with an HIV-1 Fusion Inhibitor Peptide as a Potential Microbicide

E. Sánchez-López, A. Calpena, Ignacio Pérez-Pomeda, 2020, Pharmaceutics.

Study at the Air/Water Interface of a Hepatitis A N-Acetylated and C-Amidated Synthetic Peptide (AcVP3(110–121)–NH2): I. Surface Activity and Insertion in Lipid Monolayers

M. Espina, I. Haro, M. Alsina, 2001 .

Interaction of antimicrobial arginine-based cationic surfactants with liposomes and lipid monolayers.

M. Infante, J. Castillo, I. Haro, 2004, Langmuir : the ACS journal of surfaces and colloids.

Analysis of the perturbation of phospholipid model membranes by a multiple antigenic peptide

I. Haro, M. Busquets, M. Alsina, 1995 .

Analysis of the effect of a peptide sequence of the E2 protein (HGV/GBV-C) on the physicochemical properties of zwitterionic and negatively charged bilayers.

I. Haro, M. Busquets, J. Prat, 2005, Luminescence : the journal of biological and chemical luminescence.

Lipophilic derivatization of synthetic peptides belonging to NS3 and E2 proteins of GB virus-C (hepatitis G virus) and its effect on the interaction with model lipid membranes.

I. Haro, N. Rojo, M. Alsina, 2003, The journal of peptide research : official journal of the American Peptide Society.

Antibodies to citrullinated human fibrinogen synthetic peptides in diagnosing rheumatoid arthritis.

I. Haro, R. Sanmartí, G. Ercilla, 2007, Journal of medicinal chemistry.

Implications of Post-Translational Modifications in Autoimmunity with Emphasis on Citrullination, Homocitrullination and Acetylation for the Pathogenesis, Diagnosis and Prognosis of Rheumatoid Arthritis

I. Haro, R. Sanmartí, M. Gómara, 2022, International journal of molecular sciences.

Spectroscopic analysis of the interaction of a peptide sequence of Hepatitis G virus with bilayers.

I. Haro, N. Rojo, M. Busquets, 2003, Talanta.

Physicochemical interaction of opioid peptides with phospholipids and membranes

I. Haro, M. Busquets, M. Alsina, 1991 .

Synthetic peptides for the immunodiagnosis of human diseases.

I. Haro, M J Gómara, I Haro, 2007, Current medicinal chemistry.

Synthesis and biological activity of substance P analogues.

I. Haro, J. García-Antón, J. Torres, 2009, International journal of peptide and protein research.

Analysis of the interaction with biomembrane models of the HAV-VP3(101-121) sequence conjugated to synthetic branched chain polypeptide carriers with a poly[L-lysine] backbone

F. Hudecz, I. Haro, M. Alsina, 1998 .

Assessment of synthetic chimeric multiple antigenic peptides for diagnosis of GB virus C infection.

I. Haro, G. Ercilla, M. Gómara, 2010, Analytical biochemistry.

Surface behavior of peptides from E1 GBV-C protein: Interaction with anionic model membranes and importance in HIV-1 FP inhibition.

I. Haro, M. Alsina, A. Cruz, 2015, Biochimica et biophysica acta.

Interaction of two overlapped synthetic peptides from GB virus C with charged mono and bilayers.

I. Haro, M. Busquets, M. Alsina, 2013, Colloids and surfaces. B, Biointerfaces.

Interactions of naloxone with lipid monolayers

I. Haro, M. Busquets, M. Alsina, 1991 .

Differences in synovial fluid cytokine levels but not in synovial tissue cell infiltrate between anti-citrullinated peptide/protein antibody-positive and –negative rheumatoid arthritis patients

I. Haro, J. Cañete, R. Sanmartí, 2013, Arthritis Research & Therapy.

Diagnostic and prognostic value of antibodies against chimeric fibrin/filaggrin citrullinated synthetic peptides in rheumatoid arthritis

I. Haro, J. Cañete, R. Sanmartí, 2009, Arthritis research & therapy.

Surface and polarization fluorescence studies on the interaction of an RGD sequence containing a Hepatitis A virus peptide with phospholipids

I. Haro, M. Alsina, I. Martin, 1995 .

Physicochemical interaction of a lipophilic derivative of HAV antigen VP3(110–121) with lipid monolayers

I. Haro, M. Alsina, P. Sospedra, 1999 .

Interaction of hepatitis A viral protein fragments with lipid mono- and bilayers

I. Haro, M. Alsina, J. García-Antón, 1993 .

Physicochemical study of hepatitis A and B peptide fragments with monolayers as membrane models

F. Rabanal, I. Haro, M. Alsina, 1992 .

Influence of the saturation chain and head group charge of phospholipids in the interaction of hepatitis G virus synthetic peptides.

J. Miñones, M. Espina, I. Haro, 2005, The journal of physical chemistry. B.

A Langmuir monolayer study of the interaction of E1(145-162) hepatitis G virus peptide with phospholipid membranes.

I. Haro, M. Busquets, M. Alsina, 2010, The journal of physical chemistry. B.

Synthesis of Overlapping Fibrin Citrullinated Peptides and their use for Diagnosing Rheumatoid Arthritis

I. Haro, R. Sanmartí, G. Ercilla, 2006, Chemical biology & drug design.

Comparative study of the diagnostic and prognostic value of antibodies against chimeric citrullinated synthetic peptides and CCP3/CCP3.1 assays

I. Haro, R. Sanmartí, M. Bleda, 2017, Clinical chemistry and laboratory medicine.

Oligonucleotide-Peptide Conjugates: Solid-Phase Synthesis under Acidic Conditions and Use in ELISA Assays

Ramon Eritja, Anna Aviñó, R. Eritja, 2012, Molecules.

Membrane fusion by an RGD-containing sequence from the core protein VP3 of hepatitis A virus and the RGA-analogue: implications for viral infection.

I. Haro, M. Alsina, Y. Cajal, 2001, Biopolymers.

Peptide Assembly on the Membrane Determines the HIV-1 Inhibitory Activity of Dual-Targeting Fusion Inhibitor Peptides

A. Meyerhans, H. von Briesen, I. Haro, 2019, Scientific Reports.

Structural Study of a New HIV-1 Entry Inhibitor and Interaction with the HIV-1 Fusion Peptide in Dodecylphosphocholine Micelles.

I. Haro, E. Yuste, Yolanda Pérez, 2017, Chemistry.

Interfacial interactions of hydrophobic peptides with lipid bilayers.

I. Haro, M. Alsina, M. A. Egea, 2002, Journal of colloid and interface science.

Cell penetrating peptides-functionalized Licochalcone-A-loaded PLGA nanoparticles for ocular inflammatory diseases: evaluation of in vitro anti-proliferative effects, stabilization by freeze-drying and characterization of an in-situ forming gel

A. Silva, A. Camins, E. Souto, 2023, International Journal of Pharmaceutics.

Design and application of GB virus C (GBV-C) peptide microarrays for diagnosis of GBV-C/HIV-1 co-infection

I. Haro, M. Bleda, M. Gómara, 2012, Analytical and Bioanalytical Chemistry.

Effect of synthetic peptides belonging to E2 envelope protein of GB virus C on human immunodeficiency virus type 1 infection.

C. Gil, H. Tillmann, I. Haro, 2010, Journal of medicinal chemistry.

Interaction of GB virus C/hepatitis G virus synthetic peptides with lipid langmuir monolayers and large unilamellar vesicles.

M. Espina, I. Haro, N. Vila-Romeu, 2009, Journal of Physical Chemistry B.

Behaviour of a peptide sequence from the GB virus C/hepatitis G virus E2 protein in Langmuir monolayers: its interaction with phospholipid membrane models.

I. Haro, M. Alsina, M. Nieto-Suárez, 2009, Biophysical chemistry.

Physicochemical study of laminin-related peptides

I. Haro, M. Alsina, M. Pujol, 1997 .

Importance of structure-based studies for the design of a novel HIV-1 inhibitor peptide

P. Ziprin, A. Meyerhans, C. Herrera, 2020, Scientific Reports.

Peptide Assembly on the Membrane Determines the HIV-1 Inhibitory Activity of Dual-Targeting Fusion Inhibitor Peptides

A. Meyerhans, H. von Briesen, I. Haro, 2019, Scientific Reports.

A new continuous epitope of hepatitis A virus

A. Bosch, R. Pintó, I. Haro, 1998, Journal of medical virology.

Liposome destabilization induced by synthetic lipopeptides corresponding to envelope and non-structural domains of GBV-C/HGV virus. Conformational requirements for leakage.

I. Haro, N. Rojo, M. Fernández-Vidal, 2008, Biophysical chemistry.

3D-Structure of the interior fusion peptide of HGV/GBV-C by 1H NMR, CD and molecular dynamics studies.

I. Haro, E. Ragg, M. C. Bellucci, 2007, Archives of biochemistry and biophysics.

Biophysical investigations of GBV-C E1 peptides as potential inhibitors of HIV-1 fusion peptide.

I. Haro, P. Urban, M. Busquets, 2011, Chemphyschem : a European journal of chemical physics and physical chemistry.

Synthesis and immunogenic response of hepatitis A virus-related peptides: Study of the cleavage conditions of arginine- and tryptophan-containing peptides

A. Bosch, I. Haro, R. Gajardo, 1993 .

Different approaches to potentiate the immune response induced by a 12-mer synthetic peptide.

I. Haro, M. Gómara, 2000, Current protein & peptide science.

Synthetic peptides of hepatitis G virus (GBV-C/HGV) in the selection of putative peptide inhibitors of the HIV-1 fusion peptide.

I. Haro, E. Ragg, S. Mazzini, 2009, The journal of physical chemistry. B.

Effect of chain length of HAV-VP3 synthetic peptides on its interaction with biomembrane models.

I. Haro, M. Alsina, P. Sospedra, 2000, Biopolymers.

Interactions between rheumatoid arthritis antibodies are associated with the response to anti-tumor necrosis factor therapy

C. Díaz-Torné, A. Julià, S. Marsal, 2021, BMC Musculoskeletal Disorders.

Fluorescence study on the interaction of a multiple antigenic peptide from hepatitis A virus with lipid vesicles.

I. Haro, M. Alsina, Y. Cajal, 2000, Biopolymers.

Interaction of a Multiple Antigenic Peptide of Hepatitis A Virus with Monolayers and Bilayers of Acidic, Basic, and Zwitterionic Phospholipids

I. Haro, M. Alsina, Y. Cajal, 1998 .

Interactions of a tetravalent branched peptide from VP3 capsid protein of hepatitis A virus with monolayers as biomembrane models

I. Haro, F. Reig, Mónica Garcı́a, 1997 .

SYNTHESIS OF RGD CONTAINING PEPTIDES. COMPARATIVE STUDY OF THEIR INCORPORATION TO THE SURFACE OF 5-FLUORURIDINE LOADED LIPOSOMES

I. Haro, M. Alsina, A. Massaguer, 2001, Journal of liposome research.

Physicochemical characterization of several peptide constructs related with hepatitis A and B viruses

I. Haro, M. Alsina, V. Girona, 1999 .

Solid-Phase Synthesis of the Exposed Capsid Peptide VP2(96-107) of the Hepatitis A Virus. Study of Its Physicochemical Interactions with Phospholipids

I. Haro, M. Alsina, M. A. Egea, 1996 .

Interactions of the HAV-VP3 (61-78) peptide with mono- and bilayers

I. Haro, M. Alsina, F. Reig, 1994 .

Synthesis and physicochemical study of hepatitis A viral-VP1 protein peptides

I. Haro, M. Alsina, F. Feig, 1994 .

Interaction study of peptide from VP3 capsid protein of hepatitis A virus through monolayers and fluorescence spectroscopy.

I. Haro, M. Busquets, J. Prat, 2001, Luminescence : the journal of biological and chemical luminescence.

Interaction of enrofloxacin with phospholipid mono- and bilayers

I. Haro, M. Busquets, M. Alsina, 1994 .

Liposome entrapment and immunogenic studies of a synthetic lipophilic multiple antigenic peptide bearing VP1 and VP3 domains of the hepatitis A virus: a robust method for vaccine design

I. Haro, Guadalupe Ercilla, Isabel Haro, 2003, FEBS letters.

Interaction of three beta-interferon domains with liposomes and monolayers as model membranes.

M. Espina, I. Haro, M. Alsina, 2004, Biophysical chemistry.

The covalent coupling of HAV-VP3 (110-121) synthetic peptide to liposomes: physicochemical studies.

I. Haro, P. Sospedra, M. Muñoz, 2004, International journal of pharmaceutics.

Study of adsorption and penetration of E2(279-298) peptide into Langmuir phospholipid monolayers.

J. Miñones, I. Haro, M. Busquets, 2006, The journal of physical chemistry. B.

Nanotechnology-based platforms for vaginal delivery of peptide microbicides.

E. Sánchez-López, I. Haro, M. Gómara, 2020, Current medicinal chemistry.

GB virus C (GBV-C) / hepatitis G virus (HGV): towards the design of synthetic peptides-based biosensors for immunodiagnosis of GBV-C/HGV infection.

I. Haro, N. Rojo, Guadalupe Ercilla, 2003, Current protein & peptide science.

Anti-carbamylated protein antibodies are associated with early abatacept response in rheumatoid arthritis. Comment on: Anti-carbamylated protein antibodies as a clinical response predictor in rheumatoid arthritis patients treated with abatacept.

S. Marsal, I. Haro, R. Sanmartí, 2021, Clinical and experimental rheumatology.

Conformational study of the preferred conformations of the peptide sequence VP3(110–121) of HAV by circular dichroism and molecular mechanics

J. Cantó, I. Haro, N. B. Centeno, 1997, Letters in Peptide Science.

Antibodies against β-fibrin synthetic peptides: a study of their association with the immunogenetic background and disease course of rheumatoid arthritis patients.

I. Haro, R. Sanmartí, J. Gómez-Puerta, 2011, European journal of medicinal chemistry.

Synthesis, lipophilic derivatization and interaction with liposomes of HAV-VP3 (102-121) sequence by using spectroscopic techniques.

I. Haro, M. Alsina, M. Pujol, 1996, The Analyst.

Perturbations induced by synthetic peptides from hepatitis G virus structural proteins in lipid model membranes: a fluorescent approach.

I. Haro, M. Alsina, C. Larios, 2005, Luminescence (Chichester, England Print).

Effect of E1(64-81) hepatitis G peptide on the in vitro interaction of HIV-1 fusion peptide with membrane models.

I. Haro, M. Busquets, M. Alsina, 2011, Biochimica et biophysica acta.

A Langmuir monolayer study of the interaction of E1(145-162) hepatitis G virus peptide with phospholipid membranes.

I. Haro, M. Alsina, M. Pujol, 2010, The journal of physical chemistry. B.

Behaviour of a peptide sequence from the GB virus C/hepatitis G virus E2 protein in Langmuir monolayers: its interaction with phospholipid membrane models.

I. Haro, M. Alsina, M. Nieto-Suárez, 2009, Biophysical chemistry.

Liposomes as vehicles for the presentation of a synthetic peptide containing an epitope of hepatitis A virus.

I. Haro, M. Alsina, M A Alsina, 1999, Vaccine.

Miscibility and Langmuir Studies of the Interaction of E2 (279-298) Peptide Sequence of Hepatitis G Virus/GB Virus-C with Dipalmitoylphosphatidyl Choline and Dimiristoylphosphatidyl Choline Phospholipids.

I. Haro, M. Busquets, M. Alsina, 2015, Langmuir : the ACS journal of surfaces and colloids.